US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

21.01

-0.3576-1.67%

Post-market: 20.99-0.0189-0.09%16:47 EDT

Volume:11.38K

Turnover:247.84K

Market Cap:2.31M

PE:- -

High:22.60

Open:20.78

Low:20.78

Close:21.37

52wk High:39.54

52wk Low:14.95

Shares:110.00K

Float Shares:110.00K

Volume Ratio:0.51

T/O Rate:10.34%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

US FDA Advisers Vote in Favor of Recommending Covid Vaccines Target Jn.1 Lineage Xfg Variant for 2026-27 Campaign

THOMSON REUTERS

Moderna Advances mRNA Lyme Disease Vaccine Into Phase 2: What Investors Should Watch

Syneos Health names Greg Licholai chief medical officer effective June 1

Moderna Is Prepared to Supply Recommended Covid Vaccine Composition for 2026-27 Season by Mid-August: Briefing Docs

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MRNX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":21.0089,"timestamp":1780084800000,"preClose":21.3665,"halted":0,"volume":11377,"hourTrading":{"tag":"盘后","latestPrice":20.99,"preClose":21.0089,"latestTime":"16:47 EDT","volume":12,"amount":251.7778,"timestamp":1780087665104,"change":-0.0189,"changeRate":-0.0009,"amplitude":0},"delay":0,"changeRate":-0.016736480003744083,"floatShares":110000,"shares":110000,"eps":0,"marketStatus":"Market Closed","change":-0.3576,"latestTime":"05-29 16:00:00 EDT","open":20.78,"high":22.6,"low":20.78,"amount":247841,"amplitude":0.08518,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1780300800000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":21.3665,"sharesOutstanding":30000,"nav":21.37,"aum":2350700,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":21.6,"preClose":21.3665,"latestTime":"06:02 EDT","volume":407,"amount":8556.989408,"timestamp":1780048964426,"change":0.2335,"changeRate":0.010928,"amplitude":0.041654},"postHourTrading":{"tag":"盘后","latestPrice":20.99,"preClose":21.0089,"latestTime":"16:47 EDT","volume":12,"amount":251.7778,"timestamp":1780087665104,"change":-0.0189,"changeRate":-0.0009,"amplitude":0},"volumeRatio":0.5061304682875933},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":110000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5061304682875933,"shares":110000,"dividePrice":0,"high":22.6,"amplitude":0.08518,"preClose":21.3665,"low":20.78,"week52Low":14.95,"pbRate":"--","week52High":39.535,"institutionHeld":0,"latestPrice":21.0089,"eps":0,"divideRate":0,"volume":11377,"delay":0,"ttmEps":0,"open":20.78,"prevYearClose":20.61,"prevWeekClose":20.805,"prevMonthClose":20.7722,"prevQuarterClose":26.2923,"fiveDayClose":21.292,"twentyDayClose":20.7722,"sixtyDayClose":35.4537},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639618234","title":"US FDA Advisers Vote in Favor of Recommending Covid Vaccines Target Jn.1 Lineage Xfg Variant for 2026-27 Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2639618234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639618234?lang=en_us&edition=fundamental","pubTime":"2026-05-29 02:26","pubTimestamp":1779992787,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nFWN4250W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","BK4585","LU0225284248.USD","BK4533","SGXZ57979304.SGD","BK4532","LU1894683348.USD","SG9999002224.SGD","BK4568","BK4547","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0306806265.USD","IE00BLSP4452.SGD","LU0306807586.USD","LU0225771236.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","MRNX","LU1894683264.USD","BK4588","MRNA","BK4501","BK4551","IE0002270589.USD","IE00B3T34201.USD","SG9999013999.USD","BK4581","LU1066053197.SGD","BK4007","SG9999003800.SGD","SG9999001176.SGD","BK4139","MRNY","LU1066051498.USD","NVAX","SG9999002232.USD","LU0321505868.SGD","BK4592","BK4550","LU0170899867.USD","LU0868494617.USD","SG9999011175.SGD","LU1057294990.SGD","LU0234572021.USD","LU0058720904.USD","LU0321505439.SGD","LU0456855351.SGD","LU0985481810.HKD","LU1883839398.USD","LU0289739699.SGD","BK4548","PFE","BK4534","BK4599","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639697491","title":"Moderna Advances mRNA Lyme Disease Vaccine Into Phase 2: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2639697491","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639697491?lang=en_us&edition=fundamental","pubTime":"2026-05-29 00:33","pubTimestamp":1779986006,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) announced an update on their ongoing clinical study. The Phase 2 study “A Phase 2, Randomized, Observer-blind, Dose-finding, Placeb...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moderna-advances-mrna-lyme-disease-vaccine-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moderna-advances-mrna-lyme-disease-vaccine-into-phase-2-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","ISBC","BK4534","BK4501","MRNA","BK4568","BK4139","BK4585","BK4588","BK4211","BK4548","BK4533","MRNX","BK4532","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638955976","title":"Syneos Health names Greg Licholai chief medical officer effective June 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2638955976","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638955976?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:48","pubTimestamp":1779972524,"startTime":"0","endTime":"0","summary":"He will lead global medical and scientific functions, aiming to sharpen medical strategy across clinical and commercial teams.Licholai previously served as chief medical and innovation officer at ICON, president of rare disease at Moderna, was a McKinsey partner.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Syneos Health Inc. published the original content used to generate this news brief on May 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL8SJrrF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4548","BK4585","MRNA","BK4568","BK4533","BK4534","BK4588","MRNY","MRNX","BK4532","BK4139","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638938406","title":"Moderna Is Prepared to Supply Recommended Covid Vaccine Composition for 2026-27 Season by Mid-August: Briefing Docs","url":"https://stock-news.laohu8.com/highlight/detail?id=2638938406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638938406?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:18","pubTimestamp":1779970689,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nL4N425173:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4551","BK4568","BK4533","BK4548","MRNY","BK4501","BK4585","BK4532","MRNA","BK4139","MRNX","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}